Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)
Volume 96 | IMPE2023

IMPE 2023

Buenos Aires, Argentina
04 Mar 2023 - 07 Mar 2023

Card image cap
11th International Meeting of Pediatric Endocrinology (IMPE 2023). 4 -7 March 2023 - Buenos Aires, Argentina.

ePoster Presentations

Adrenals and HPA Axis

impe0096ep1 | Adrenals and HPA Axis | IMPE2023

POR (P450 oxidoreductase) deficiency: report of a case

Acuna Pilar , Barnafi Esteban , De Tezanos Pinto Andres , Mira Magdalena , Romero Patricio , Iniguez German , Vivanco Maritza

Congenital adrenal hyperplasia (CAH) is a monogenic autosomal recessive disorder that may involve different steroidogenic enzymes. POR (P450 oxidoreductase) deficiency is a rare variant of unknown incidence and is the most complex form of CAH. POR is an electron-donating enzyme for CYP17A1, CYP21A2, and CYP19A1. Clinically it can be observed as a combined deficiency of CYP17A1, CYP21A2, and secondary to the donating defect to aromatase, the mother can become virilized during p...

impe0096ep2 | Adrenals and HPA Axis | IMPE2023

Paraganglioma in pediatric patient: Case report of a 13-year-old Girl

Carreiro Sabliny , Pinho Henrique , Bressiani Marina , Hertz Michele , Cristofari Luciele , Puñales Marcia

Background: Paragangliomas (PGL) and pheochromocytomas (PHEO) are rare neuroendocrine tumors in children, derived from chromaffin cells in the adrenal medulla or associated with paravertebral ganglia, and produce dopamine and catecholamines (norepinephrine, and epinephrin). Case presentation: A previously healthy 13-year-old girl, developed a severe pulsating headache associated with tachycardia, sweating, weight loss an...

impe0096ep3 | Adrenals and HPA Axis | IMPE2023

Avaliation of overwheigh frenquency in children and teenager with congenital adrenal hyperplasia

Paganini Emily , Orlandi Rafael , Ramirez Paloma , Kochi Cristiane

Background: Recent research has indicated an association between patients with CAH and higher incidence of obesity associated with cardiovascular risk. Individuals with congenital adrenal hyperplasia suffers from 21-hydroxylase deficiency, which leads to lack of cortisol and aldosterone, causing androgen excess. Early diagnosis and treatment are essential to prevent morbidity and mortality, both of which are increased on CAH patients in comparison to populatio...

impe0096ep4 | Adrenals and HPA Axis | IMPE2023

Infant with primary hypoaldosteronism due to aldosterone synthase deficiency

Viterbo Gisela , Ciaccio Marta , Martinez Castillo Iratxe , Sabbarese Luciana , Florencia Soto María , Manuel Lazzati Juan , Perez Garrido Natalia , Marino Roxana , Costanzo Mariana

Background: Aldosterone synthase is a cytochrome P450 enzyme encoded by the CYP11B2 gene and responsible of the conversion of dehydrocorticosterone to aldosterone through three enzymatic steps: addition of the 11b-hydroxyl group to form corticosterone, 18-hydroxylation to form 18-hydroxycorticosterone, and 18-dehydrogenation to form aldosterone. Two types of aldosterone synthase deficiency have been reported: type I related to defects in 18-hydroxilation, and ...

impe0096ep5 | Adrenals and HPA Axis | IMPE2023

A Case with Late-Onset Familial Congenital Lipoid Adrenal Hyperplasia

Noordin Mazidah , Miyagi Hajime , Igarashi Mizuho , Horikawa Reiko

Congenital Lipoid Adrenal Hyperplasia (CLAH) is the most severe form of congenital adrenal hyperplasia. It is caused by mutation in the steroidogenic acute regulatory protein (StAR) gene, which can be of autosomal recessive inheritance. A 6-year-old girl, with a background of recurrent febrile seizure, presented with history of seizure, preceded by 1-day history of fever. On presentation, she had reduced consciousness, hypoglycemia with refractory hypotensive shock. She was in...

impe0096ep6 | Adrenals and HPA Axis | IMPE2023

Adrenoleukodystrophy: A Case Report

Pigola Isabel , Finozzi Rosa , Arguiñarena Nadia , Otazú Magdalena , Risso Mariana , Saccone Sofía , Piñeyro Mercedes , Mendoza Beatriz

Introduction: Adrenoleukodystrophy (ALD) is an X linked disorder caused by mutations in the ABCD1 gene which determine a peroxisomal defect that increases plasmatic levels of Very Long Chain Fatty Acids (VLCFA). This disease has an incidence of 1/20.000 births, with onset between 4 and 12 years old. It causes an irreversible loss of myelin in the brain and cerebellum and a progressive dysfunction of the adrenal gland that leads to adrenal insufficiency. Clinic...